
Keywords: 2-AG; arachidonoylglycerol; AI; alkylindole; CB; cannabinoid; CB1; cannabinoid receptor 1; CB2; cannabinoid receptor 2; CSA4; combretastatin A4; DBT; delayed Brain Tumor; HA; hemagglutinin; LPA; lysophosphatidic acid; GBM; glioblastoma multiforme; SAR; st